BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,104,294 | -52.1% | 461,717 | -36.4% | 0.00% | -60.0% |
Q2 2023 | $23,181,979 | +15.0% | 726,025 | +10.3% | 0.01% | +25.0% |
Q1 2023 | $20,155,860 | -49.4% | 658,258 | -35.4% | 0.00% | -55.6% |
Q4 2022 | $39,829,311 | -20.5% | 1,018,392 | -3.2% | 0.01% | -25.0% |
Q3 2022 | $50,102,000 | +35.7% | 1,051,676 | +10.2% | 0.01% | +50.0% |
Q2 2022 | $36,927,000 | -22.3% | 953,927 | +15.0% | 0.01% | -20.0% |
Q1 2022 | $47,516,000 | -38.8% | 829,247 | -14.9% | 0.01% | -33.3% |
Q4 2021 | $77,619,000 | -14.6% | 974,018 | -6.7% | 0.02% | -21.1% |
Q3 2021 | $90,846,000 | +8.9% | 1,044,082 | +61.1% | 0.02% | 0.0% |
Q2 2021 | $83,410,000 | +41.9% | 648,044 | -11.7% | 0.02% | +26.7% |
Q1 2021 | $58,766,000 | -14.4% | 734,217 | -12.7% | 0.02% | -16.7% |
Q4 2020 | $68,675,000 | +796.1% | 841,193 | +170.2% | 0.02% | +800.0% |
Q3 2020 | $7,664,000 | -13.0% | 311,289 | -1.0% | 0.00% | -33.3% |
Q2 2020 | $8,807,000 | +34.8% | 314,537 | -13.3% | 0.00% | +50.0% |
Q1 2020 | $6,534,000 | – | 362,958 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |